Crizotinib is an orally administered small molecule inhibitor targeting the c-Met/HGFR tyrosine kinase, exhibiting potential antineoplastic properties. It is widely used in cancer research, particularly in studies involving ALK and ROS1-driven tumors, with applications in both in vitro cellular assays and in vivo xenograft models.
Molecular Weight:
510.39
CAS Number:
[877399-53-6]
Formula:
C23H26Cl2FN5O3
Target:
ALK,Others,c-Met/HGFR,ROS Kinase
* VAT and and shipping costs not included. Errors and price changes excepted
